2 min read

UBC Appoints Nathan Thompson Chief Information Officer

Effective January 2, 2023, Nathan Thompson will assume the role of Chief Information Officer of UBC.
Effective January 2, 2023, Nathan Thompson will assume the role of Chief Information Officer of UBC.

BLUE BELL, P.A., December 15, 2022 (PR NEWSWIRE) – UBC, a biopharmaceutical leader providing integrated clinical, safety, and commercialization services, announced today that Nathan Thompson has joined UBC and, effective January 2, 2023, will assume the role of Chief Information Officer.

Nathan joins UBC most recently from Premier Research, where he served as their Chief Information Officer and Head of Corporate Real Estate, and brings more than 20 years of complex technology, operational, and corporate strategy to UBC. With experience spanning the hospital administration and life sciences industries, he will support UBC’s vision with a strategic approach to product design through technology innovations.

“As we consider the next level of growth for UBC, we recognize the importance of innovative and differentiated technology solutions as well as technology to drive real world evidence generation,” said Patrick Lindsay, President & Chief Executive Officer, UBC. “To ensure UBC’s long-term strategic growth, we must have industry-leading products, streamlined IT processes, and effective operational controls in place. I believe that with Nathan’s addition to the already outstanding leadership team, we strengthen our evidence-driven model and will continue to be a leader in data-driven decisions and outcomes for the life sciences industry.”

About UBC

United BioSource LLC (UBC) is a leader in the biopharmaceutical market that provides integrated clinical, safety, and commercialization services. UBC combines renowned scientific research and operations experts with innovative technologies, allowing for the best patient and healthcare provider experience. Comprehensive, end-to-end services cover product and patient population characterization during development and market entry, as well as a focus on the patient experience, safety, and adherence. For additional information, visit www.ubc.com.

MEDIA INQUIRIES

Amber Frasketi

UBC

Phone: 215.588.8423

Email: amber.frasketi@ubc.com

Other Recent Posts

Press
5 min read

UBC Announces Partnership with Osmind to Advance the Future of Mental Health Treatment and Research within REMS

First-of-its-kind partnership in mental health care reduces REMS implementation burden, improves the quality of REMS data, and optimizes safe medication use and health outcomes
Press
5 min read

UBC and Thread Expand SitePlus Offering and Active Studies with BioPharma Sponsors to Optimize Evidence Generation

This augments the central site model with additional research services and tech to widen recruitment and improves site and patient experience.
Press
3 min read

UBC Appoints Anthony Luttenberger Chief Commercial Officer

Biopharma services industry veteran brings decades of experience spanning late-stage, clinical trials, & post-approval commercial support.
UBC logo white

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

UBC logo white

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown Headshot

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.